Research Article
The Cuproptosis-Related Long Noncoding RNA Signature Predicts Prognosis and Immune Cell Infiltration in Hepatocellular Carcinoma
Table 1
The consistency test results of HCC clinical traits.
| Covariates | Types | Total | Test group | Train group | value |
| Age | ≤65 | 232 (62.7%) | 107 (57.84%) | 125 (67.57%) | 0.0676 | >65 | 138 (37.3%) | 78 (42.16%) | 60 (32.43%) |
| Gender | Female | 121 (32.7%) | 60 (32.43%) | 61 (32.97%) | 1 | Male | 249 (67.3%) | 125 (67.57%) | 124 (67.03%) |
| Grades | G1 | 55 (14.86%) | 24 (12.97%) | 31 (16.76%) | 0.7163 | G2 | 177 (47.84%) | 93 (50.27%) | 84 (45.41%) | G3 | 121 (32.7%) | 60 (32.43%) | 61 (32.97%) | G4 | 12 (3.24%) | 6 (3.24%) | 6 (3.24%) | Unknow | 5 (1.35%) | 2 (1.08%) | 3 (1.62%) |
| Stages | Stage I | 171 (46.22%) | 87 (47.03%) | 84 (45.41%) | 0.7738 | Stage II | 85 (22.97%) | 42 (22.7%) | 43 (23.24%) | Stage III | 85 (22.97%) | 38 (20.54%) | 47 (25.41%) | Stage IV | 5 (1.35%) | 3 (1.62%) | 2 (1.08%) | Unknow | 24 (6.49%) | 15 (8.11%) | 9 (4.86%) |
| T | T1 | 181 (48.92%) | 93 (50.27%) | 88 (47.57%) | 0.7336 | T2 | 93 (25.14%) | 49 (26.49%) | 44 (23.78%) | T3 | 80 (21.62%) | 36 (19.46%) | 44 (23.78%) | T4 | 13 (3.51%) | 6 (3.24%) | 7 (3.78%) | Unknow | 3 (0.81%) | 1 (0.54%) | 2 (1.08%) |
| M | M0 | 266 (71.89%) | 137 (74.05%) | 129 (69.73%) | 1 | M1 | 4 (1.08%) | 2 (1.08%) | 2 (1.08%) | Unknow | 100 (27.03%) | 46 (24.86%) | 54 (29.19%) |
| N | N0 | 252 (68.11%) | 120 (64.86%) | 132 (71.35%) | 0.5598 | N1 | 4 (1.08%) | 3 (1.62%) | 1 (0.54%) | Unknow | 114 (30.81%) | 62 (33.51%) | 52 (28.11%) |
|
|